BioCentury
ARTICLE | Company News

Ambrilia cancer, infectious news

February 16, 2009 8:00 AM UTC

Ambrilia retained Boenning & Scattergood Inc. to review strategic alternatives. The company also said it has completed its previously announced headcount reductions, including its CSO and Senior EVP B...